ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,828.40
-0.09%
다우존스 지수
40,211.72
0.53%
Bitcoin
62,735.84
-3.26%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Carisma Therapeutics Inc (CARM)

  7. Carisma Therapeutics Inc (CARM) 뉴스

CARM

Carisma Therapeutics (CARM)

Carisma Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CARM
일자시간출처헤드라인심볼기업
2024/05/0620:30PR Newswire (US)Carisma Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:CARMCarisma Therapeutics Inc
2024/05/0220:30PR Newswire (US)Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical OfficerNASDAQ:CARMCarisma Therapeutics Inc
2024/04/2506:05PR Newswire (US)Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
2024/04/2501:43Business WireCarmila : Lancement d’un programme de rachat d’actions pour 10 millions d’eurosNASDAQ:CARMCarisma Therapeutics Inc
2024/04/2501:43Business WireCarmila: Launch of a Share Buyback Program for €10 MillionNASDAQ:CARMCarisma Therapeutics Inc
2024/04/2305:35PR Newswire (US)Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
2024/04/1800:45Business WireCarmila : Information financière au 31 mars 2024NASDAQ:CARMCarisma Therapeutics Inc
2024/04/1800:45Business WireCarmila: First-quarter 2024 Financial InformationNASDAQ:CARMCarisma Therapeutics Inc
2024/04/0600:45Business WireCarmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
2024/04/0600:45Business WireCarmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
2024/04/0320:00PR Newswire (US)Carisma Therapeutics to Present at Upcoming ConferencesNASDAQ:CARMCarisma Therapeutics Inc
2024/04/0121:35PR Newswire (US)Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CARMCarisma Therapeutics Inc
2024/04/0120:00PR Newswire (US)Carisma Therapeutics Announces Changes to its Board of DirectorsNASDAQ:CARMCarisma Therapeutics Inc
2024/03/2206:00PR Newswire (US)Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
2024/03/1601:45Business WireCARMILA : INFORMATION RELATIVE A LA REMUNERATION DES DIRIGEANTS MANDATAIRES SOCIAUXNASDAQ:CARMCarisma Therapeutics Inc
2024/03/1601:45Business WireCarmila: Information Relating to Executive Corporate Officer CompensationNASDAQ:CARMCarisma Therapeutics Inc
2024/03/1601:45Business WireCarmila : Communiqué de mise à disposition du Document d’enregistrement universel 2023NASDAQ:CARMCarisma Therapeutics Inc
2024/03/1601:45Business WireCarmila: Filing of the 2023 Universal Registration DocumentNASDAQ:CARMCarisma Therapeutics Inc
2024/03/0901:45Business WireCORRIGE ET REMPLACE : Carmila : Evolution de la composition du Conseil d’administration suite au Conseil d’administration du 7 mars 2024NASDAQ:CARMCarisma Therapeutics Inc
2024/03/0901:45Business WireCORRECTING and REPLACING: Carmila: Changes in the composition of the Board of Directors following the meeting of the Board of Directors on 7 March 2024NASDAQ:CARMCarisma Therapeutics Inc
2024/03/0806:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CARMCarisma Therapeutics Inc
2024/03/0803:13Business WireCARMILA : Evolution de la composition du Conseil d’administration suite au Conseil d’administration du 7 mars 2024NASDAQ:CARMCarisma Therapeutics Inc
2024/03/0803:13Business WireCARMILA: Changes in the composition of the Board of Directors following the meeting of the Board of Directors on 7 March 2024NASDAQ:CARMCarisma Therapeutics Inc
2024/03/0501:45Business WireCarmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
2024/03/0501:45Business WireCarmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
2024/02/2821:30PR Newswire (US)Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:CARMCarisma Therapeutics Inc
2024/02/1401:45Business WireCarmila : Résultats annuels 2023NASDAQ:CARMCarisma Therapeutics Inc
2024/02/1401:45Business WireCarmila: 2023 Annual ResultsNASDAQ:CARMCarisma Therapeutics Inc
2024/02/0306:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARMCarisma Therapeutics Inc
2024/02/0303:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CARMCarisma Therapeutics Inc
 검색 관련기사 보기:NASDAQ:CARM

최근 히스토리

NASDAQ
NYNY
Empire Resorts
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유